Biosidus S.A.U.

About Biosidus S.A.U.

Biosidus is engaged in the development, manufacturing and commercialization of high-quality recombinant proteins. Since the launch of Erythropoetin in 1990, Biosidus has successively marketed the following biosimilars: Interferon Alfa 2a, Interferon Alfa 2b, Filgrastim, Somatropin, Lenograstim, Azacitidine, Bortezomib, Interferon beta 1a (SC and IM) and Teriparatide. Today, these products are being commercialized in more than 50 markets.
With headquarters and manufacturing plants located in Buenos Aires, Argentina, we have developed regional hubs in order to intensify our pres...

  • AR
  • 2015
    On CPHI since
  • 2
  • 500 - 999
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Biosidus S.A.U. (5)

Biosidus S.A.U. Resources (2)